Article Text

Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: a clinical conundrum
  1. Charleen Min Li Chan Wah Hak1,
  2. Yew Oo Tan2,
  3. Charles Chan2
  1. 1School of Clinical Medicine, University of Cambridge, Cambridge, UK
  2. 2Gleneagles Medical Centre, Singapore, Singapore
  1. Correspondence to Charleen Min Li Chan Wah Hak, charleen.chan{at}gmail.com

Summary

A patient with long-standing immune thrombocytopenic purpura (ITP) would logically contradict antiplatelet use due to increased bleeding risk during coronary stenting. Coronary stenting using an endothelial progenitor cells (EPC) capture stents (GenousTM) was used to successfully revascularise our patient using a transradial approach. The only complication was extensive superficial ecchymosis on the patient's forearm from antiplatelet use, which resolved spontaneously. To the best of our knowledge, this is the first case report of EPC capture stents in a chronic ITP patient.

View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.